Yin F Q, Chen Q, Sprecher H
Department of Medical Biochemistry, The Ohio State University, 337 Hamilton Hall, 1645 Neil Avenue, Columbus, OH 43210, USA.
Biochim Biophys Acta. 1999 Apr 19;1438(1):63-72. doi: 10.1016/s1388-1981(99)00039-6.
The unsaturated fatty acid composition of phospholipids from different tissues frequently varies. Rat liver phospholipids contain esterified 22:6(n-3) while 22:5(n-6) is the major esterified 22-carbon acid in testes phospholipids. Both testes and liver synthesize polyunsaturated fatty acids. Microsomes, particularly from liver, have been used extensively to measure reaction rates as they relate to polyunsaturated fatty acid and phospholipid biosynthesis. None of these rate studies explain why specific acids are synthesized and subsequently esterified. In this study we compared the metabolism of [3-14C]-labeled (n-3) and (n-6) acids when injected via the tail vein, as a measure of hepatic metabolism, versus when they were injected directly into the testes. Liver preferentially metabolizes [3-14C]-labeled 24:5(n-3) and 24:6(n-3) to yield esterified 22:6(n-3), when compared with the conversion of [3-14C]-labeled 24:4(n-6) and 24:5(n-6) to yield 22:5(n-6). Both 24-carbon (n-3) acids were also converted to 22:5(n-3) but no labeled 22:4(n-6) was detected after injecting the two 24-carbon (n-6) acids. Differences in the hepatic metabolism of 24-carbon (n-3) and (n-6) acids to 22:6(n-3) and 22:5(n-6), versus their partial beta-oxidation to 22:5(n-3) and 22:4(n-6), are important in vivo controls. Surprisingly, in testes a higher percentage of radioactivity was found in esterified 22:6(n-3) versus 22:5(n-6) following injections, respectively, of [3-14C]-labeled 22:5(n-3) versus 22:4(n-6), which is the corresponding metabolic analog. Corresponding pairs of 24-carbon (n-3) and (n-6) acids, as they relate to metabolism, were processed in similar ways by testes. The relative absence of esterified 22-carbon (n-3) fatty acids, versus the abundance of 22- and 24-carbon (n-6) acids in testes phospholipids, does not appear per se to be due to differences in the ability of testes to metabolize (n-3) and (n-6) fatty acids. It remains to be determined if there is selective uptake of specific fatty acids by testes for use as precursors to synthesize polyunsaturated fatty acids.
不同组织中磷脂的不饱和脂肪酸组成常常有所不同。大鼠肝脏磷脂含有酯化的22:6(n-3),而22:5(n-6)是睾丸磷脂中主要的酯化22碳脂肪酸。睾丸和肝脏都能合成多不饱和脂肪酸。微粒体,尤其是肝脏微粒体,已被广泛用于测量与多不饱和脂肪酸和磷脂生物合成相关的反应速率。这些速率研究均未解释为何会合成特定的酸并随后进行酯化。在本研究中,我们比较了经尾静脉注射时[3-14C]标记的(n-3)和(n-6)酸的代谢情况,以此作为肝脏代谢的一种衡量指标,同时也比较了将它们直接注射到睾丸中的代谢情况。与[3-14C]标记的24:4(n-6)和24:5(n-6)转化生成22:5(n-6)相比,肝脏优先将[3-14C]标记的24:5(n-3)和24:6(n-3)代谢生成酯化的22:6(n-3)。两种24碳(n-3)酸也会转化为22:5(n-3),但在注射两种24碳(n-6)酸后未检测到标记的22:4(n-6)。24碳(n-3)和(n-6)酸在肝脏中代谢生成22:6(n-3)和22:5(n-6),与它们部分β-氧化生成22:5(n-3)和22:4(n-6)之间的差异,在体内调控中具有重要意义。令人惊讶的是,在睾丸中,分别注射[3-14C]标记的22:5(n-3)和22:4(n-6)(它们是相应的代谢类似物)后,酯化的22:6(n-3)中的放射性百分比高于22:5(n-6)。睾丸以类似方式处理与代谢相关且对应的24碳(n-3)和(n-6)酸对。睾丸磷脂中酯化的22碳(n-3)脂肪酸相对缺乏,而22碳和24碳(n-6)酸含量丰富,这本身似乎并非由于睾丸代谢(n-3)和(n-6)脂肪酸能力的差异所致。睾丸是否会选择性摄取特定脂肪酸作为合成多不饱和脂肪酸的前体,仍有待确定。